BLCM
Bellicum Pharmaceuticals Inc

5,687
Mkt Cap
$894,666.00
Volume
6,059.00
52W High
$1.31
52W Low
$0.06
PE Ratio
-0.06
BLCM Fundamentals
Price
$0.0748
Prev Close
$0.0801
Open
$0.0801
50D MA
$0.1088
Beta
0.84
Avg. Volume
20,295.50
P/B
-0.03
Loading...
Loading...
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Bellicum Pharmaceuticals Inc?
What is the 52-week high for Bellicum Pharmaceuticals Inc?
What is the 52-week low for Bellicum Pharmaceuticals Inc?
What is Bellicum Pharmaceuticals Inc stock price today?
What was Bellicum Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Bellicum Pharmaceuticals Inc?
What is the Price-to-Book ratio of Bellicum Pharmaceuticals Inc?
What is the 50-day moving average of Bellicum Pharmaceuticals Inc?

Latest BLCM News

View
No BLCM news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.